FDA official logo
GSRS logoPFDA official logo

SEMORINEMAB

UNII:O8DG8VI95O
Formula:
Preferred Substance Name:SEMORINEMAB

  • 2159141-27-0
  • IMMUNOGLOBULIN G4, ANTI-(HUMAN TAU PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL RO7105705 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RO7105705 .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS MAPT (MICROTUBULE-ASSOCIATED PROTEIN TAU, TAU)), MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN (1-444) (VH (HOMO SAPIENS IGHV3-23*03 (88.7%)-(IGHD)-IGHJ4*01 (100%)) (8.8.10) (1-117)-HOMO SAPIENS IGHG4*01 (CH1 (118-215), HINGE S10>P (225) (216-227), CH2 M15.1>Y (249), S16>T (251), T18>E (253) (228-337), CH3 (338-442), CHS (443-444)) (118-444)), (131-219')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-219') (V-KAPPA (MUS MUSCULUS IGKV1-117*01 (90.0%)-IGKJ4*01(83.3%)/HOMO SAPIENS IGKV2-4*01 (85.4%)-IGKJ1*01 (100%)) (11.3.9) (1'-112')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (158), V101 (196) (113'-219'))DIMER (223-223'':226-226'')-BISDISULFIDE
  • IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS MICROTUBULE-ASSOCIATED PROTEIN TAU (NEUROFIBRILLARY TANGLE PROTEIN, PAIRED HELICAL FILAMENT-TAU, PHF-TAU))MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-444) (VH (HOMO SAPIENS IGHV3-23*03 (89%) (IGHD)-IGHJ4*01) (8.8.10) (1-117)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(225)), CH2(M22>Y(249),S24>T(251),T26>E(253))) (118-444)), (131-219')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-219') (V-KAPPA (MUS MUSCULUS IGKV1-117*01 (90%) IGKJ1*01 (83%) (11.3.10)/HOMO SAPIENS IGKV2-40*01 (85%) IGKJ1*01 (11.3.9)) (1'-112')-HOMO SAPIENS IGKC*01 (113'-219')), DIMER (223-223'':226-226'')-BISDISULFIDE
  • MTAU9937A
  • MTAU-9937A
  • RO7105705
  • RO-7105705
  • SEMORINEMAB [INN]
  • SEMORINEMAB [USAN]
  • SEMORINEMAB [WHO-DD]




UNII - O8DG8VI95O | UNII Search Service